Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.
Saved in:
| Title: | Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers. |
|---|---|
| Authors: | Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Won HH; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Loxo Oncology at Lilly, Stamford, CT, USA., Zheng Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cocco E; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; University of Miami, Miller School of Medicine, Department of Biochemistry and Molecular Biology/Sylvester Comprehensive Cancer Center, Miami, FL, USA., Selcuklu D; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gong Y; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Friedman ND; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Bruijn I; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sumer O; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bielski CM; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Savin C; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bourque C; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Falcon C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Clarke N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jing X; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Meng F; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zimel C; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shifman S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kittane S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ebata K; Loxo Oncology at Lilly, Stamford, CT, USA., Kherani J; Loxo Oncology at Lilly, Stamford, CT, USA., Brandhuber BJ; Loxo Oncology at Lilly, Stamford, CT, USA., Fagin J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sherman EJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rekhtman N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berger MF; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Scaltriti M; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; AstraZeneca, Waltham, MA, USA., Hyman DM; Loxo Oncology at Lilly, Stamford, CT, USA., Taylor BS; Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.; Weill Cornell Medical College, New York, NY, USA. taylor.lab.msk@gmail.com.; Loxo Oncology at Lilly, Stamford, CT, USA. taylor.lab.msk@gmail.com., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. drilona@mskcc.org. |
| Source: | Nature communications [Nat Commun] 2022 Apr 05; Vol. 13 (1), pp. 1936. Date of Electronic Publication: 2022 Apr 05. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-29700-y |
